Profile
Ross A.
Reife held several positions in the pharmaceutical industry, including Vice President-Global Medical Affairs at Wyeth Pharmaceuticals LLC, Chief Medical Officer at Neurovance, Inc., and Chief Medical Officer at SAGE Therapeutics, Inc. Prior to these roles, he was a Principal at Johnson & Johnson Pharmaceutical Group from 1992 to 2013.
Reife earned an MBA from The Trustees of Columbia University in The City of New York in 1999 and completed his undergraduate studies at the University of Pennsylvania.
Former positions of Ross A. Reife
| Companies | Position | End |
|---|---|---|
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
| Johnson & Johnson Pharmaceutical Group | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | - |
| SAGE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Ross A. Reife
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Johnson & Johnson Pharmaceutical Group | |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Ross A. Reife
